Clinical
RSSArticles
-
Temporal Relationship Between Atrial Fibrillation and Ischemic Stroke?
Multiple hours of atrial fibrillation had a strong but transient effect raising stroke risk, suggesting that a strategy of intermittent targeted usage of rapidly acting anticoagulants might merit further consideration by a randomized trial.
-
Aortic Valve Replacement in Asymptomatic Patients: Can Registry Data Replace Randomized, Controlled Trials?
Patients with severe asymptomatic aortic stenosis managed conservatively have “dismal” outcomes in real-world practice.
-
Optimal Beta-blocker Dose Post-MI
ABSTRACT & COMMENTARY: A look at survival rates using high and low doses of beta blockers.
-
Clinical Briefs
In this section: managing osteoporosis, comparing treatments for hypertension, and uric acid as a predictor of hypertension.
-
Idarucizumab Injection (Praxbind)
Idarucizumab effectively reverses the anticoagulant effect of dabigatran and has minimal side effects.
-
Treatment for Ulnar Neuropathy at the Elbow
In a randomized treatment trial of steroid injection into the cubital tunnel for ulnar neuropathy, there was no difference in outcome compared to placebo.
-
Eat Breakfast, Fix Insulin Resistance in Patients with Type 2 Diabetes
Breakfast consumption could be a successful strategy for reducing postprandial hyperglycemia in patients with type 2 diabetes.
-
Eat Right, Preserve Your Memory, and Stay Happy
Greater intake of unhealthy food and lower intake of nutrient-dense food is associated with a smaller hippocampus over 4 years in adults 60-64 years of age.
-
Antibiotic Use and Risk of Diabetes
More frequent users of antibiotics were more likely to be diagnosed with type 2 diabetes than those who had taken the drugs infrequently.
-
Bisphosphonates May Impact Bone Recurrence in Postmenopausal Women with Breast Cancer
Although the rate of distant recurrence and breast cancer mortality were statistically and significantly superior in women who had been treated with bisphosphonates, the absolute degree of benefit was of dubious clinical relevance.